中东和非洲医药市场 Omega-3 成分 - 行业趋势和 2030 年预测

中东和非洲医药 Omega-3 成分市场分析及规模

消费者对食用 DHA 和 EPA 等 omega-3 脂肪酸的益处的认识不断提高，这是促进市场增长的主要因素。广泛的科学研究和媒体曝光，以及非洲消费者健康和营养意识的提高，导致过去五年中 omega-3 鱼油补充剂的销量大幅增加。中东和非洲生活方式和与年龄相关的疾病的增加，因此促进了补充剂和功能性食品部门的增长，收入份额为 52%。

 Data Bridge Market Research 分析了 2023-2030 年预测期内医药市场 omega-3 成分的增长率。在上述预测期内，医药市场 omega-3 成分的预期复合年增长率约为 8.9%。2022 年市场价值为 1356 万美元，到 2030 年将增长至 2682 万美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

中东和非洲医药用 Omega-3 成分市场范围和细分

Market Definition

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega 3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.

Middle East and Africa Omega-3 Ingredients for Pharmaceuticals Market Dynamics

Drivers

• Increasing Self-sufficiency in Domestic Meat or Poultry Production

During the last few decades, the demand for poultry across countries, such as the Kingdom of Saudi Arabia, has increased promptly which eventually led the small, medium, and large domestic chicken meat producers to have close consultations and collaborations with the Saudi Ministry of Environment, Water, and Agriculture (MEWA) to surge chicken and meat production in the upcoming years and decrease the country’s heavy dependence on imported chicken meat. The increasing preference for chicken having higher weight and meat maintaining its flavour, tenderness, and shelf life have led to increased imports of omega-3 associated feeds into the region. Thus, this factor increases the growth of the market.

• Rising Technological Advancements

Technological advancements and product innovation is anticipated to boost the market for omega 3 ingredients during the forecast period. For instance, DSM introduced new 3C technology to reinvigorate omega 3 supplements category on October 6, 2016. Furthermore, on June 9, 2015, Croda introduced Incromega DHA and approved by European Food Safety Authority (EFSA). Additionally, Royal DSM collaborated with Evonik to manufacture omega 3 fatty acid products from natural marine algae for animal nutrition on March 8, 2017. This innovation will allow the production of omega 3 fatty acids for animal nutrition without using fish oil. This factor improves the market growth.

Opportunities

• Increasing Internet Usage in Promoting Health Awareness

Growing consumer awareness associated with the health benefits from the consumption of omega-3 supplements in developed and developing countries is a huge opportunity for the market. Dietary supplements are the ultimate choice for health-conscious consumers. To meet their recommended dietary quotas, people of several age groups consume dietary supplements. Omega-3 is used in several dietary supplements and is becoming extremely popular among consumers. The high indulgence of western lifestyle has led to an increase in the rate of consumption of dietary supplements across several developing countries. Thus, this boost the market growth.

• Rising Research Activities

Numerous research studies have developed a link between consumption of fatty fish and lowering of coronary heart diseases. For instance, fish oils are widely used as a supplement to balance the required dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Furthermore, fish oil is normally recommended as a supplement product for people who suffer from myocardial infarction by the American Heart Association, World Health Organization (WHO), the National Heart Foundation of Australia and National Health and Medical Research Council (NHMRC). Thus, this factor helps to create much opportunities for the growth of the market.

Restraints/Challenges

• Side Effects of omega-3 ingredients

There are various side-effects associated with the omega-3 ingredients for pharmaceuticals. Effects such as burping, diarrhea, heartburn, joint pain, stomach pain or discomfort, vomiting, constipation, nausea. Thus, these adverse effects affect the growth rate by decreasing the adoption of omega-3. This impedes the market growth.

• Increasing Negative Consumer Perception About omega-3 ingredients

Negative consumer perception associated with the smell and taste of omega-3 ingredients is also anticipated to limit the growth of the market. These unstable fatty acids can damage through enzymatic or chemical oxidation to form compounds that give foods a fishy smell. Additionally, fresh fish oil has no fishy taste or smell, just like fresh fish. People feel hesitant to adopt for omega-3 ingredients. Thus, this hampers the market growth.

This omega-3 ingredients for pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the omega-3 ingredients for pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, Omega-3 related supplier GC Rieber VivoMega announced its plans to enhance production facilities and storage tanks to accommodate more ingredients in the upcoming years.
• In 2021, KD Pharma Group introduced Alga3, a sustainable, vegan omega-3 solution. KD Nutra's superior technology and production flexibility enable for a huge range of omega-3 concentrates. The company can personalize the EPA and DHA ratio on customer needs, and for any kd-pür fish oil, there is a matching Alga3 plant-based solution.

Middle East and Africa Omega-3 Ingredients for Pharmaceuticals Market Scope

The omega-3 ingredients for pharmaceuticals market is segmented on the basis of source, type, forms, therapeutic areas, population type, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Marine
• Plant

Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-Linolenic Acid (ALA)

Forms

• Liquid
• Dry

Therapeutic Areas

• Cardiovascular Diseases
• Autoimmune Diseases
• Bone & Joint Disorders
• Neurological Disorders
• Ophthalmic Disorders
• Skin Health
• Cancer
• Others

Population Type

• Adults
• Children

Distribution Channel

• Direct
• Indirect

Omega-3 Ingredients for Pharmaceuticals Market Regional Analysis/Insights

The omega-3 ingredients for pharmaceuticals market is analyzed and market size insights and trends are provided by source, type, forms, therapeutic areas, population type, and distribution channel as referenced above.

The major countries covered in the omega-3 ingredients for pharmaceuticals market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America has been witnessing a positive growth for Omega-3 ingredients for pharmaceuticals market throughout the forecasted period because of growing usage of pharmaceutical products that contains omega-3 ingredients for prevention of cardiovascular disease. The increasing demand for healthy food in North America because of the growing awareness increased foodborne diseases and increasing food industry is anticipated to drive the growth of this Middle East and Africa market during the forecast period.

South America dominates the market because of the growing rate of expansion, especially by international players, enabling them to increase domestic production capabilities. Also, the growing demand of functional and supplements food particularly from the marine segment combined with the rising awareness associated with the benefits of the omega-3 is enhancing the market growth.

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析的同时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和中东和非洲医药用 Omega-3 成分市场份额分析

药品用 omega-3 成分市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对药品用 omega-3 成分市场的关注有关

药品用 Omega-3 成分市场的主要参与者包括：

• Avestia Pharma（印度）
• Novasep（法国）
• AbbVie Inc.（美国）
• KD制药集团（日本）
• 巴斯夫公司（德国）
• Corbion（荷兰）
• 帝斯曼（荷兰）
• 阿斯利康（英国）
• 葛兰素史克公司（英国）
• 费森尤斯卡比公司（德国）
• Croda International Plc（美国）
• AMARIN CORPORATION（爱尔兰）
• ANI Pharmaceuticals, Inc.（美国）
• Epax（挪威）
• Strides Pharma Science Limited（印度）
• Pharma Marine AS（挪威）
• KinOmega Biopharm Inc. (中国)
• Camber Pharmaceuticals, Inc.（美国）

SKU-55585